| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/27/2006 | WO2005117590A3 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 07/27/2006 | WO2005114206A3 Diagnostics and therapeutics for diseases associated with serotonin 5-ht5a receptor (5ht5a) |
| 07/27/2006 | WO2005113565A3 Metabolites of selective androgen receptor modulators and methods of use thereof |
| 07/27/2006 | WO2005111078A3 Anti-cea scfv-beta-lactamase contructs (cab molecules) in adept |
| 07/27/2006 | WO2005111057A3 Immunostimulatory nucleic acids for inducing il-10 responses |
| 07/27/2006 | WO2005110483A3 Use of targeted oxidative therapeutic formulation in bone regeneration |
| 07/27/2006 | WO2005110480A3 Combination of organic compounds |
| 07/27/2006 | WO2005107705A3 Extended therapeutic effect ocular implant treatments |
| 07/27/2006 | WO2005104696A3 Non-gmo metal amino acid chelates and non-gmo metal amino acid chelate-containing compositions |
| 07/27/2006 | WO2005101979A3 Method of food intake management |
| 07/27/2006 | WO2005097187A3 Methods of preventing uvb-induced skin damage |
| 07/27/2006 | WO2005097090A3 AGENTS THAT DISRUPT PSD95 - nNOS INTERACTION, COMPOSITIONS CONTAINING THE SAME, AND THERAPEUTIC USES THEREOF |
| 07/27/2006 | WO2005089317A3 Immune response modifier formulations and methods |
| 07/27/2006 | WO2005089068A3 Pharmaceutical compositions comprising anti-inflammatory quinazolinecarboxamide derivatives |
| 07/27/2006 | WO2005081904A3 Antimicrobial carbohydrates and methods of using same |
| 07/27/2006 | WO2005077332A3 Stable sustained-release oral dosage forms of gabapentin and process for preparation thereof |
| 07/27/2006 | WO2005075454A3 SALT FORMS OF 4-(4-METHYLPIPERAZIN-1-YLMETHYL)-n-[4-METHYL-3-(4-PYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO)PHENYL]-BENZAMIDE |
| 07/27/2006 | WO2005074898A3 Composition comprising (s) pantoprazole and an antibiotic for treating helicobacter pylori |
| 07/27/2006 | WO2005067673A3 Enzymatic method to produce 7-dehydropregnenolone, vitamin d3-like compounds and derivatives thereof |
| 07/27/2006 | WO2005062979A3 Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics |
| 07/27/2006 | WO2005061466A9 Novel phenylalanine derivative |
| 07/27/2006 | WO2005051304A3 Akt protein kinase inhibitors |
| 07/27/2006 | WO2005020894A3 Rifamycin analogs and uses thereof |
| 07/27/2006 | WO2004110339A3 Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
| 07/27/2006 | WO2004073620A3 The selective and specific preparation of discrete peg compounds |
| 07/27/2006 | WO2004064762A9 Novel cocrystallization |
| 07/27/2006 | US20060168690 Transforming a plant cell using an expression recombinant vector including a DNA encoding hyaluronic acid synthase, growing a transformant obtained then separating the hyaluronic acid produced |
| 07/27/2006 | US20060168667 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 07/27/2006 | US20060167290 Method of separating ergosterol |
| 07/27/2006 | US20060167289 Efficient and inexpensive method to prepare ubiquinone precursors using benzenoid precursor with retention of the double bond stereochemistry; industrial scale; carbolumination of alkynes |
| 07/27/2006 | US20060167271 Purified compounds that inhibit intracellular alphax4/paxillin binding |
| 07/27/2006 | US20060167269 Compounds and methods for the inhibition of compounds cruzi |
| 07/27/2006 | US20060167267 Michael-type addition of a nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and the conversion of a ester moiety into an amino moiety; S)-2-methylcysteine; desferrithiocin |
| 07/27/2006 | US20060167266 1,2,4- thiadiazole compounds and use thereof |
| 07/27/2006 | US20060167265 Process for making amlodipine, derivatives thereof, and precursors therefor |
| 07/27/2006 | US20060167261 e.g. N-(4-Chloro-3-trifluoro methyl phenyl)-2-[3-(4-pyridinyloxy)phenyl amino]-acetamide; serine/threonine kinase inhibitor; anticarcinogenic, antiproliferative, antidiabetic agent; autoimmune diseases; atherosclerosis, arthritis, Crohn's disease, retinopaty |
| 07/27/2006 | US20060167255 Tetralin and indane derivatives and uses thereof |
| 07/27/2006 | US20060167253 substituted diaminopyrimidine compounds having HIV inhibiting properties; reacting 4-(2-cyanoethenyl)-2,6-dimethylbenzenamine with an intermediate (4-cyano, 2-pyrimidine- aniline derivative; reaction with acrylonitril |
| 07/27/2006 | US20060167252 Imidazo[1,2-a]pyridine derivatives for treatment of herpes viral infections |
| 07/27/2006 | US20060167251 CCR9 inhibitors and methods of use thereof |
| 07/27/2006 | US20060167248 Substituted morpholine and thiomorpholine derivatives |
| 07/27/2006 | US20060167246 (E)-3-[4-({1-[(11-cyclohexyl-8-methoxy-4,5-dihydro-6-oxa-1-thia-3b-azabenzo[e]cyclopenta[a]azulene-2-carbonyl)amino]cyclobutanecarbonyl}amino)phenyl]acrylic acid; RNA-dependent RNA polymerase inhibitory activity; hepatitis C |
| 07/27/2006 | US20060167242 Cephalosporin in crystalline form |
| 07/27/2006 | US20060167237 Derivatives of monosaccharides for drug discovery |
| 07/27/2006 | US20060167223 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use |
| 07/27/2006 | US20060167116 Solubilising polysaccharides substituted with dydrophilic and hydrophobic groups |
| 07/27/2006 | US20060167114 Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors |
| 07/27/2006 | US20060167113 Process for preparation of polymorphic form of sertraline hydrochloride |
| 07/27/2006 | US20060167112 Methods and compositions for regulating memory consolidation |
| 07/27/2006 | US20060167111 Methods for treating an impairment in memory consolidation |
| 07/27/2006 | US20060167110 R(-)N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane; oral, transdermal or injection drug delivery; can be co-administered with a second antiischemic agent |
| 07/27/2006 | US20060167109 Methods of reducing rhinovirus contagion and related compositions |
| 07/27/2006 | US20060167108 Neuroprotective benzoate and benzamide compounds |
| 07/27/2006 | US20060167107 Amide derivatives of the compound anacardic acid from Cashew Nut Shell Oil; to treat cancer, AIDS, HIV infection, and asthma |
| 07/27/2006 | US20060167106 Compounds acting at the centrosome |
| 07/27/2006 | US20060167105 CCR-3 receptor antagonists |
| 07/27/2006 | US20060167104 Method for extracting a novel compound from the root of a plant of the pentadiplandraceae family and use of N,N'-dibenzylthiourea as a medicine |
| 07/27/2006 | US20060167103 Methods of treating cancer with HDAC inhibitors |
| 07/27/2006 | US20060167102 Compositions comprising cyclopentane derivatives and their use |
| 07/27/2006 | US20060167101 Therapeutic use of D-methionine to reduce the toxicity of noise |
| 07/27/2006 | US20060167100 Orodispersible pharmaceutical composition of an antithrombotic compound |
| 07/27/2006 | US20060167099 Use of compositions that increase glutamate receptor activity in treatment of brain injury |
| 07/27/2006 | US20060167098 Method for the treatment of diseases linked to an accumulation of triglycerides and cholesterol |
| 07/27/2006 | US20060167097 Compositions and uses of Amooranin compounds |
| 07/27/2006 | US20060167096 Livestock products with an increased ppar/rxr heterodimer activator level |
| 07/27/2006 | US20060167095 Method for treating amyloidosis |
| 07/27/2006 | US20060167094 Satiety agent |
| 07/27/2006 | US20060167093 inhibit the generation of melanin; to improve the skin pigmentation; with low stimuli and toxicity to skin and enhanced stability of whitening components in the cosmetic formulations; 5-methyl-2-(methylethylphenyl)-2-(3,4,5-trimethoxyphenyl)acetate |
| 07/27/2006 | US20060167092 Lipophilic diesters of chelating agent for inhibition of enzyme activity |
| 07/27/2006 | US20060167090 BTK inhibitors |
| 07/27/2006 | US20060167089 Method for inhibition or treatment of colon tumorigenesis |
| 07/27/2006 | US20060167088 Methods and compositions for treating ophthalmic conditions with retinyl derivatives |
| 07/27/2006 | US20060167087 Substituted aniline derivatives |
| 07/27/2006 | US20060167086 Medicinal composition |
| 07/27/2006 | US20060167084 Delta-9-THC compositions and methods for treating symptoms associated with multiple sclerosis |
| 07/27/2006 | US20060167083 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures |
| 07/27/2006 | US20060167082 4-Nitrooxybutyl 4-(2,6-Dichlorophenylamino)-thiophen-3-ylacetate; cytoprotective nitric oxide releasing nonsteroidal antiinflammatory agents; cyclooxygenase inhibitors; reduced side effects |
| 07/27/2006 | US20060167081 Ep4 receptor agonists |
| 07/27/2006 | US20060167080 Use in inhibiting PI-3-kinase activity in mammals; cancer; Acetic acid 4-diallylaminomethylene-6-hydroxy-1- alpha -methoxymeth-yl-10 beta ,13 beta -dimethyl-3,7,17-trioxo-1,3,4,7,10,11 beta , 12,13,14 alpha ,15,16,17-dodecahydro-2-oxa-cyclopenta[ alpha ]phenanthren-11-yl ester |
| 07/27/2006 | US20060167079 For treating thrombosis and factor xa-related cardiovascular and neurodegenerative diseases; (1E)-N-(1-{4-[2-(1-Azetidinylmethyl)-1H-imidazol-1-yl]-2-fluorophenyl}-2-oxo-3-pyrrolidinyl)-2-(5-chloro-2-thienyl)-1-propene-1-sulfonamide for example |
| 07/27/2006 | US20060167078 Substituted benzodioxepins |
| 07/27/2006 | US20060167077 Process for preparation of carvedilol |
| 07/27/2006 | US20060167076 Acutumine and acutumine compounds synthesis and use |
| 07/27/2006 | US20060167075 Modulators of FAAH |
| 07/27/2006 | US20060167074 Methods and compositions for the treatment of psychiatric disorders |
| 07/27/2006 | US20060167073 Liquid pharmaceutical formulations of palonosetron |
| 07/27/2006 | US20060167072 Liquid pharmaceutical formulations of palonosetron |
| 07/27/2006 | US20060167071 Liquid pharmaceutical formulations of palonosetron |
| 07/27/2006 | US20060167070 Triazole compounds that modulate Hsp90 activity |
| 07/27/2006 | US20060167069 Pharmaceutical composition of metaxalone with enhanced oral bioavailability |
| 07/27/2006 | US20060167068 Method of treating self-injurious behavior with glutamate modulating agents |
| 07/27/2006 | US20060167067 Gm-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent |
| 07/27/2006 | US20060167066 Pyrrolidine inhibitors of IAP |
| 07/27/2006 | US20060167065 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 07/27/2006 | US20060167064 Pharmaceutical liquid composition containing pyridone derivative |
| 07/27/2006 | US20060167063 Process for the manufacture of isradipine |
| 07/27/2006 | US20060167062 Enema preparation |
| 07/27/2006 | US20060167061 Removing a OH, Cl, Br, mesyl, or tosyl group from the 2-position on the ethoxy of 5-[4-[2-(alkyl substituted pyridyl)ethoxy]benzyl-2,4-thiazolidinedione by reaction with a zinc or acetic acid reducing agent in an alcoholic solvent |
| 07/27/2006 | US20060167059 Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 07/27/2006 | US20060167058 PPAR-activating compound |